
    
      All eligible patients who consent to the study will be randomized to one of three groups.
      Group 1 will receive a TAP block with 60 mL 0.25% bupivacaine. Group 2 will receive a TAP
      block with 20 mL liposomal bupivacaine and 40 mL saline. Group 3 will receive a TAP block
      with 20 mL liposomal bupivacaine and 40 mL 0.25% bupivacaine. Patients will be assessed in
      the post-anesthesia care unit (PACU) at once each on Post-operative day 1,2, and 3.
    
  